TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVES
2.4 MARKET STRUCTURE
2.5 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 GROWING ADOPTION OF EMERGING TECHNOLOGIES AND ANALYTICAL TOOLS
4.2.2 REGULATION OF R&D PRODUCTIVITY
4.2.3 GROWING TREND OF THE BIG DATA ADVERTISEMENT IN PHARMA SECTOR
4.2.4 INCREASING USAGE OF ANALYTICAL TOOLS IN STREAMLINING BUSINESS PROCESS
4.3 RESTRAINTS
4.3.1 SCARCITY OF LABOR AND HIGH LABOR COST
4.3.2 CONSERVATIVE NATURE OF HEALTHCARE INDUSTRY
4.4 OPPORTUNITY
4.4.1 GROWING TREND OF OUTSOURCING
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 PRODUCT DEVELOPMENT & BUSINESS ACQUISITION (PDBA)
5.1.2 MARKETING AND DISTRIBUTION
5.1.3 CONTRACT MANAGEMENT
5.1.4 CUSTOMER SERVICE & SUPPORT
5.2 PORTER’S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS:
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT FROM SUBSTITUTES
5.2.4 BARGAINING POWER OF BUYERS:
5.2.5 INTENSITY OF RIVALRY:
5.3 COVID-19 IMPACT ANALYSIS
5.3.1 IMPACT ON ADOPTION OF SOFTWARE
5.3.2 IMPACT ON ACCEPTANCE OF CLOUD-BASED TECHNOLOGIES
5.3.3 IMPACT ON KEY PLAYERS
5.3.4 IMPACT ON PRICING
6 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE
6.1 OVERVIEW
6.2 DESCRIPTIVE ANALYTICS
6.3 PREDICTIVE ANALYTICS
6.4 PRESCRIPTIVE ANALYTICS
7 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS
7.1 OVERVIEW
7.2 SOFTWARE
7.3 SERVICES
8 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 DATA ANALYTICS
8.3 COMMERCIAL EXCELLENCE
8.4 DATA MANAGEMENT
8.5 R&D
8.6 CLINICAL
9 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT
9.1 OVERVIEW
9.2 ON-PREMISES
9.3 WEB-BASED/CLOUD-BASED
10 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION
10.1 OVERVIEW
10.2 AMERICAS
10.2.1 NORTH AMERICA
10.2.1.1 US
10.2.1.2 CANADA
10.2.2 LATIN AMERICA
10.3 EUROPE
10.3.1 WESTERN EUROPE
10.3.1.1 GERMANY
10.3.1.2 UK
10.3.1.3 FRANCE
10.3.1.4 ITALY
10.3.1.5 SPAIN
10.3.1.6 REST OF WESTERN EUROPE
10.3.2 EASTERN EUROPE
10.4 ASIA PACIFIC
10.4.1 JAPAN
10.4.2 CHINA
10.4.3 INDIA
10.4.4 AUSTRALIA
10.4.5 SOUTH KOREA
10.4.6 REST OF ASIA PACIFIC
10.5 MIDDLE EAST & AFRICA
10.5.1 MIDDLE EAST
10.5.2 AFRICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 COMPETITIVE BENCHMARKING
11.3 MAJOR GROWTH STRATEGY IN COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET
11.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET
11.5 KEY DEVELOPMENT ANALYSIS
11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
11.6.1 PRODUCT APPROVALS AND PRODUCT LAUNCHES
11.6.2 PARTNERSHIP/COLLABORATION/INVESTMENT
11.6.3 BUSINESS EXPANSIONS/AGREEMENTS
11.6.4 MERGERS & ACQUISITIONS
11.7 MAJOR PLAYERS SALES ANALYSIS
11.7.1 SALES & OPERATING INCOME
11.8 MAJOR PLAYERS R&D ANALYSIS
12 COMPANY PROFILES
12.1 D CUBE ANALYTICS
12.1.1 COMPANY OVERVIEW
12.1.2 FINANCIAL ANALYSIS
12.1.3 PRODUCTS OFFERED
12.1.4 KEY DEVELOPMENTS
12.1.5 KEY STRATEGIES
12.2 GENPACT
12.2.1 COMPANY OVERVIEW
12.2.2 FINANCIAL OVERVIEW
12.2.3 PRODUCTS OFFERED
12.2.4 KEY DEVELOPMENTS
12.2.5 KEY STRATEGIES
12.3 AUROCHS
12.3.1 COMPANY OVERVIEW
12.3.2 FINANCIAL ANALYSIS
12.3.3 PRODUCTS 0FFERED
12.3.4 KEY DEVELOPMENTS
12.3.5 KEY STRATEGIES
12.4 THEMATHCOMPANY
12.4.1 COMPANY OVERVIEW
12.4.2 FINANCIAL ANALYSIS
12.4.3 PRODUCTS OFFERED
12.4.4 KEY DEVELOPMENTS
12.4.5 KEY STRATEGIES
12.5 AXTRIA
12.5.1 COMPANY OVERVIEW
12.5.2 FINANCIAL ANALYSIS
12.5.3 PRODUCTS OFFERED
12.5.4 KEY DEVELOPMENTS
12.5.5 KEY STRATEGIES
12.6 ZS
12.6.1 COMPANY OVERVIEW
12.6.2 FINANCIAL ANALYSIS
12.6.3 PRODUCTS OFFERED
12.6.4 KEY DEVELOPMENTS
12.6.5 KEY STRATEGIES
12.7 INDEGENE
12.7.1 COMPANY OVERVIEW
12.7.2 FINANCIAL ANALYSIS
12.7.3 PRODUCTS OFFERED
12.7.4 KEY DEVELOPMENTS
12.7.5 KEY STRATEGIES
12.8 TIGER ANALYTICS
12.8.1 COMPANY OVERVIEW
12.8.2 FINANCIAL ANALYSIS
12.8.3 PRODUCTS 0FFERED
12.8.4 KEY DEVELOPMENTS
12.8.5 KEY STRATEGIES
12.9 BEGHOU CONSULTING
12.9.1 COMPANY OVERVIEW
12.9.2 FINANCIAL ANALYSIS
12.9.3 PRODUCTS OFFERED
12.9.4 KEY DEVELOPMENTS
12.9.5 KEY STRATEGIES
12.10 TACT.AI TECHNOLOGIES, INC.
12.10.1 COMPANY OVERVIEW
12.10.2 FINANCIAL ANALYSIS
12.10.3 PRODUCTS OFFERED
12.10.4 KEY DEVELOPMENTS
12.10.5 KEY STRATEGIES
12.11 ANAPLAN, INC.
12.11.1 COMPANY OVERVIEW
12.11.2 FINANCIAL ANALYSIS
12.11.3 PRODUCTS/SERVICES/SOLUTIONS OFFERED
12.11.4 KEY DEVELOPMENTS
12.11.5 KEY STRATEGIES
12.12 IBM
12.12.1 COMPANY OVERVIEW
12.12.2 FINANCIAL OVERVIEW
12.12.3 PRODUCTS/SERVICES/SOLUTIONS OFFERED
12.12.4 KEY DEVELOPMENTS
12.12.5 SWOT ANALYSIS
12.12.6 KEY STRATEGIES
12.13 COGNIZANT
12.13.1 COMPANY OVERVIEW
12.13.2 FINANCIAL OVERVIEW
12.13.3 PRODUCTS/SERVICES/SOLUTIONS OFFERED
12.13.4 KEY DEVELOPMENTS
12.13.5 KEY STRATEGIES
12.14 ACCENTURE
12.14.1 COMPANY OVERVIEW
12.14.2 FINANCIAL OVERVIEW
12.14.3 PRODUCTS/SERVICES/SOLUTIONS OFFERED
12.14.4 KEY DEVELOPMENTS
12.14.5 SWOT ANALYSIS
12.14.6 KEY STRATEGIES
12.15 MEDIDATA SOLUTIONS
12.15.1 COMPANY OVERVIEW
12.15.2 FINANCIAL OVERVIEW
12.15.3 PRODUCTS/SERVICES/SOLUTIONS OFFERED
12.15.4 KEY DEVELOPMENTS
12.15.5 KEY STRATEGIES
12.16 CITIUSTECH INC.
12.16.1 COMPANY OVERVIEW
12.16.2 FINANCIAL OVERVIEW
12.16.3 PRODUCTS/SERVICES/SOLUTIONS OFFERED
12.16.4 KEY DEVELOPMENTS
12.16.5 KEY STRATEGIES
12.17 PHARMAACE
12.17.1 COMPANY OVERVIEW
12.17.2 FINANCIAL OVERVIEW
12.17.3 PRODUCTS/SERVICES/SOLUTIONS OFFERED
12.17.4 KEY DEVELOPMENTS
12.17.5 KEY STRATEGIES
12.18 FRACTAL ANALYTICS INC.
12.18.1 COMPANY OVERVIEW
12.18.2 FINANCIAL OVERVIEW
12.18.3 PRODUCTS/SERVICES/SOLUTIONS OFFERED
12.18.4 KEY DEVELOPMENTS
12.18.5 KEY STRATEGIES
12.19 MU SIGMA
12.19.1 COMPANY OVERVIEW
12.19.2 FINANCIAL OVERVIEW
12.19.3 PRODUCTS/SERVICES/SOLUTIONS OFFERED
12.19.4 KEY DEVELOPMENTS
12.19.5 KEY STRATEGIES
12.20 WNS (HOLDINGS) LTD.
12.20.1 COMPANY OVERVIEW
12.20.2 FINANCIAL OVERVIEW
12.20.3 PRODUCTS/SERVICES/SOLUTIONS OFFERED
12.20.4 KEY DEVELOPMENTS
12.20.5 SWOT ANALYSIS
12.20.6 KEY STRATEGIES
12.21 TATA CONSULTANCY SERVICES LIMITED
12.21.1 COMPANY OVERVIEW
12.21.2 FINANCIAL OVERVIEW
12.21.3 PRODUCTS/SERVICES/SOLUTIONS OFFERED
12.21.4 KEY DEVELOPMENTS
12.21.5 SWOT ANALYSIS
12.21.6 KEY STRATEGIES
12.22 WIPRO
12.22.1 COMPANY OVERVIEW
12.22.2 FINANCIAL OVERVIEW
12.22.3 PRODUCTS/SERVICES/SOLUTIONS OFFERED
12.22.4 KEY DEVELOPMENTS
12.22.5 SWOT ANALYSIS
12.22.6 KEY STRATEGIES
12.23 VEEVA SYSTEMS INC.
12.23.1 COMPANY OVERVIEW
12.23.2 FINANCIAL OVERVIEW
12.23.3 PRODUCTS/SERVICES/SOLUTIONS OFFERED
12.23.4 KEY DEVELOPMENTS
12.23.5 KEY STRATEGIES
13 APPENDIX
13.1 REFERENCES
13.2 RELATED REPORTS
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
TABLE 3 GLOBAL: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 4 GLOBAL: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, FOR DESCRIPTIVE ANALYTICS, BY REGION, 2018–2030 (USD MILLION)
TABLE 5 GLOBAL: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, FOR PREDICTIVE ANALYTICS, BY REGION, 2018–2030 (USD MILLION)
TABLE 6 GLOBAL: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, FOR PREDICTIVE ANALYTICS, BY REGION, 2018–2030 (USD MILLION)
TABLE 7 GLOBAL: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS, 2018–2030 (USD MILLION)
TABLE 8 GLOBAL: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, FOR SOFTWARE, BY REGION, 2018–2030 (USD MILLION)
TABLE 9 GLOBAL: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, FOR SERVICES, BY REGION, 2018–2030 (USD MILLION)
TABLE 10 GLOBAL: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION, 2018–2030 (USD MILLION)
TABLE 11 GLOBAL: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, FOR DATA ANALYTICS, BY REGION, 2018–2030 (USD MILLION)
TABLE 12 GLOBAL: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, FOR COMMERCIAL EXCELLENCE, BY REGION, 2018–2030 (USD MILLION)
TABLE 13 GLOBAL: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, FOR DATA MANAGEMENT, BY REGION, 2018–2030 (USD MILLION)
TABLE 14 GLOBAL: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, FOR R&D, BY REGION, 2018–2030 (USD MILLION)
TABLE 15 GLOBAL: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, FOR CLINICAL, BY REGION, 2018–2030 (USD MILLION)
TABLE 16 GLOBAL: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT, 2018–2030 (USD MILLION)
TABLE 17 GLOBAL: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, FOR ON-PREMISES, BY REGION, 2018–2030 (USD MILLION)
TABLE 18 GLOBAL: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, FOR WEB-BASED/CLOUD-BASED, BY REGION, 2018–2030 (USD MILLION)
TABLE 19 GLOBAL: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION, 2018–2030 (USD MILLION)
TABLE 20 AMERICAS: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION, 2018–2030 (USD MILLION)
TABLE 21 AMERICAS: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 22 AMERICAS: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS, 2018–2030 (USD MILLION)
TABLE 23 AMERICAS: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION, 2018–2030 (USD MILLION)
TABLE 24 AMERICAS: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT, 2018–2030 (USD MILLION)
TABLE 25 NORTH AMERICA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COUNTRY, 2018–2030 (USD MILLION)
TABLE 26 NORTH AMERICA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 27 NORTH AMERICA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS, 2018–2030 (USD MILLION)
TABLE 28 NORTH AMERICA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION, 2018–2030 (USD MILLION)
TABLE 29 NORTH AMERICA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT, 2018–2030 (USD MILLION)
TABLE 30 US: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 31 US: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS, 2018–2030 (USD MILLION)
TABLE 32 US: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION, 2018–2030 (USD MILLION)
TABLE 33 US: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT, 2018–2030 (USD MILLION)
TABLE 34 CANADA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 35 CANADA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS, 2018–2030 (USD MILLION)
TABLE 36 CANADA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION, 2018–2030 (USD MILLION)
TABLE 37 CANADA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT, 2018–2030 (USD MILLION)
TABLE 38 LATIN AMERICA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 39 LATIN AMERICA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS, 2018–2030 (USD MILLION)
TABLE 40 LATIN AMERICA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION, 2018–2030 (USD MILLION)
TABLE 41 LATIN AMERICA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT, 2018–2030 (USD MILLION)
TABLE 42 EUROPE: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION, 2018–2030 (USD MILLION)
TABLE 43 EUROPE: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 44 EUROPE: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS, 2018–2030 (USD MILLION)
TABLE 45 EUROPE: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION, 2018–2030 (USD MILLION)
TABLE 46 EUROPE: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT, 2018–2030 (USD MILLION)
TABLE 47 WESTERN EUROPE: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COUNTRY, 2018–2030 (USD MILLION)
TABLE 48 WESTERN EUROPE: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 49 WESTERN EUROPE: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS, 2018–2030 (USD MILLION)
TABLE 50 WESTERN EUROPE: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION, 2018–2030 (USD MILLION)
TABLE 51 WESTERN EUROPE: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT, 2018–2030 (USD MILLION)
TABLE 52 GERMANY: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 53 GERMANY: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS, 2018–2030 (USD MILLION)
TABLE 54 GERMANY: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION, 2018–2030 (USD MILLION)
TABLE 55 GERMANY: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT, 2018–2030 (USD MILLION)
TABLE 56 UK: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 57 UK: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS, 2018–2030 (USD MILLION)
TABLE 58 UK: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION, 2018–2030 (USD MILLION)
TABLE 59 UK: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT, 2018–2030 (USD MILLION)
TABLE 60 FRANCE: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 61 FRANCE: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS, 2018–2030 (USD MILLION)
TABLE 62 FRANCE: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION, 2018–2030 (USD MILLION)
TABLE 63 FRANCE: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT, 2018–2030 (USD MILLION)
TABLE 64 ITALY: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 65 ITALY: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS, 2018–2030 (USD MILLION)
TABLE 66 ITALY: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION, 2018–2030 (USD MILLION)
TABLE 67 ITALY: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT, 2018–2030 (USD MILLION)
TABLE 68 SPAIN: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 69 SPAIN: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS, 2018–2030 (USD MILLION)
TABLE 70 SPAIN: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION, 2018–2030 (USD MILLION)
TABLE 71 SPAIN: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT, 2018–2030 (USD MILLION)
TABLE 72 REST OF WESTERN EUROPE: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 73 REST OF WESTERN EUROPE: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS, 2018–2030 (USD MILLION)
TABLE 74 REST OF WESTERN EUROPE: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION, 2018–2030 (USD MILLION)
TABLE 75 REST OF WESTERN EUROPE: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT, 2018–2030 (USD MILLION)
TABLE 76 EASTERN EUROPE: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 77 EASTERN EUROPE: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS, 2018–2030 (USD MILLION)
TABLE 78 EASTERN EUROPE: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION, 2018–2030 (USD MILLION)
TABLE 79 EASTERN EUROPE: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT, 2018–2030 (USD MILLION)
TABLE 80 ASIA PACIFIC: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 81 ASIA PACIFIC: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 82 ASIA PACIFIC: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS, 2018–2030 (USD MILLION)
TABLE 83 ASIA PACIFIC: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION, 2018–2030 (USD MILLION)
TABLE 84 ASIA PACIFIC: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT, 2018–2030 (USD MILLION)
TABLE 85 JAPAN: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86 JAPAN: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 87 JAPAN: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88 JAPAN: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 89 CHINA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90 CHINA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 91 CHINA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92 CHINA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 93 INDIA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94 INDIA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 95 INDIA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96 INDIA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 97 AUSTRALIA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98 AUSTRALIA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 99 AUSTRALIA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100 AUSTRALIA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 101 SOUTH KOREA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102 SOUTH KOREA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 103 SOUTH KOREA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104 SOUTH KOREA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 105 REST OF ASIA PACIFIC: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106 REST OF ASIA PACIFIC: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 107 REST OF ASIA PACIFIC: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108 REST OF ASIA PACIFIC: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 109 MIDDLE EAST & AFRICA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION, 2018-2030 (USD MILLION)
TABLE 110 MIDDLE EAST & AFRICA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 111 MIDDLE EAST & AFRICA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 112 MIDDLE EAST & AFRICA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113 MIDDLE EAST & AFRICA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 114 MIDDLE EAST: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115 MIDDLE EAST: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 116 MIDDLE EAST: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117 MIDDLE EAST: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 118 AFRICA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 119 AFRICA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 120 AFRICA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121 AFRICA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 122 MAJOR MANUFACTURERS IN COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET
TABLE 123 MOST ACTIVE PLAYER IN COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET
TABLE 124 PRODUCT APPROVALS AND PRODUCT LAUNCHES
TABLE 125 PARTNERSHIP/COLLABORATION/INVESTMENT
TABLE 126 BUSINESS EXPANSIONS/AGREEMENTS
TABLE 127 MERGERS & ACQUISITIONS
TABLE 128 D CUBE ANALYTICS: PRODUCTS OFFERED
TABLE 129 GENPACT: PRODUCTS OFFERED
TABLE 130 AUROCHS: PRODUCTS OFFERED
TABLE 131 AUROCHS: KEY DEVELOPMENTS
TABLE 132 THEMATHCOMPANY: PRODUCTS OFFERED
TABLE 133 THEMATHCOMPANY: KEY DEVELOPMENTS
TABLE 134 AXTRIA: PRODUCTS OFFERED
TABLE 135 AXTRIA: KEY DEVELOPMENTS
TABLE 136 ZS: PRODUCTS OFFERED
TABLE 137 ZS: KEY DEVELOPMENTS
TABLE 138 INDEGENE: PRODUCTS OFFERED
TABLE 139 INDEGENE: KEY DEVELOPMENTS
TABLE 140 TIGER ANALYTICS: PRODUCTS OFFERED
TABLE 141 BEGHOU CONSULTING: PRODUCTS OFFERED
TABLE 142 BEGHOU CONSULTING: KEY DEVELOPMENTS
TABLE 143 TACT.AI TECHNOLOGIES, INC.: PRODUCTS OFFERED
TABLE 144 TACT.AI TECHNOLOGIES, INC.: KEY DEVELOPMENTS
TABLE 145 ANAPLAN, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 146 IBM: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 147 IBM: KEY DEVELOPMENTS
TABLE 148 COGNIZANT: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 149 COGNIZANT: KEY DEVELOPMENTS
TABLE 150 ACCENTURE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 151 ACCENTURE: KEY DEVELOPMENTS
TABLE 152 MEDIDATA SOLUTIONS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 153 CITIUSTECH INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 154 PHARMAACE.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 155 FRACTAL ANALYTICS INC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 156 MU SIGMA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 157 WNS (HOLDINGS) LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 158 TATA CONSULTANCY SERVICES LIMITED.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 159 WIPRO: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 160 VEEVA SYSTEM INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS
FIGURE 2 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET
FIGURE 5 DRIVER IMPACT ANALYSIS
FIGURE 6 RESTRAINT IMPACT ANALYSIS
FIGURE 7 VALUE CHAIN ANALYSIS – GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET
FIGURE 8 GLOBAL: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE, 2023-2032 (USD MILLION)
FIGURE 9 GLOBAL: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS, 2023-2032 (USD MILLION)
FIGURE 10 GLOBAL: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION, 2023-2032 (USD MILLION)
FIGURE 11 GLOBAL: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT, 2023-2032 (USD MILLION)
FIGURE 12 GLOBAL: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION 2023-2032 (USD MILLION)
FIGURE 13 GLOBAL: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET SHARE (%), BY REGION, 2021
FIGURE 14 AMERICAS: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION 2023-2032 (USD MILLION)
FIGURE 15 NORTH AMERICA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET SHARE (%), BY COUNTRY 2021
FIGURE 16 EUROPE: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION 2023-2032 (USD MILLION)
FIGURE 17 WESTERN EUROPE: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET SHARE (%), BY COUNTRY 2021
FIGURE 18 ASIA PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET SHARE, BY COUNTRY 2023-2032 (USD MILLION)
FIGURE 19 ASIA PACIFIC: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET SHARE (%), BY COUNTRY, 2021
FIGURE 20 MIDDLE EAST & AFRICA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET SHARE, BY REGION 2023-2032 (USD MILLION)
FIGURE 21 MIDDLE EAST & AFRICA: COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET SHARE (%), BY REGION, 2021
FIGURE 22 BENCHMARKING OF MAJOR COMPETITORS
FIGURE 23 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET
FIGURE 24 COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET: COMPETITIVE LANDSCAPE
FIGURE 25 MAJOR PLAYERS SALES & OPERATING INCOME, 2021
FIGURE 26 MAJOR PLAYERS R&D EXPENDITURE, 2021
FIGURE 27 GENPACT: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 ANAPLAN, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 IBM: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 IBM: SWOT ANALYSIS
FIGURE 31 COGNIZANT: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 ACCENTURE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 ACCENTURE: SWOT ANALYSIS
FIGURE 34 MEDIDATA SOLUTIONS: FINANCIAL OVERVIEW
FIGURE 35 WNS (HOLDINGS) LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 36 WNS HOLDINGS LIMITED: SWOT ANALYSIS
FIGURE 37 TATA CONSULTANCY SERVICES LIMITED: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 38 TATA CONSULTANCY SERVICES LIMITED: SWOT ANALYSIS
FIGURE 39 WIPRO: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 40 WIPRO: SWOT ANALYSIS
FIGURE 41 VEEVA SYSTEM INC.: FINANCIAL OVERVIEW
